In Vitro Superiority of Dual-Chambered Peritoneal Dialysis Solution with Possible Clinical Benefits

Wieslander A.P. , Andrén A. , Martison E. , Kjellstrand P. , Hultqvist M. Toxicity of effluent peritoneal dialysis fluid. Adv Perit Dial 1993; 9: 31–5.

Wieslander A.P. , Deppisch R. , Svensson E. , Forsbäck G. , Speidel R. , Rippe B. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995; 15: 158–64.

Wieslander A. , Andrén A.H.G. , Nilsson–Thorell C. , Muscalu N. , Kjellstrand P.T.T. , Rippe B. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 1995; 15: 348–52.

Cooker L.A. , Luneburg P. , Faict D. , Choo C. , Holmes C.J. Reduced glucose degradation products in bicarbonate/ lactate-buffered peritoneal dialysis solutions produced in two-chambered bags. Perit Dial Int 1997; 17: 373–8.

Sundaram D. , Cendoroglo M. , Cooker L.A. , Jaber B.L. , Faict D. , Holmes C.J. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro. Am J Kidney Dis 1997; 30(5): 680–9.

Ing T.S. , Patel B P. , Patel J.A. , Patel N.K. , Yu A.W. , Osman A. Effects of a pH 7.4, lactate-based and a pH 7.4, bicarbonate-based peritoneal dialysis solution on neutrophil superoxide generation. Int J Artif Organs 1996; 19(12): 700–3.

Jonasson P. , Bagge U. , Wieslander A. , Braide M. Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity of rat peritoneal venules. Perit Dial Int 1996; 16(1): 137–40.

Dawnay A. Advanced glycation end products in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1): S50–3.

Nakayama M. , Kawaguchi Y. , Yamada K. , Hasegawa T. , Takazoe K. , Katoh N. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51: 182–6.

Honda K. , Nitta K. , Horita S. , Yumura W. , Nihei H. , Nagai R. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999; 14: 1541–9.

Witowski J. , Korybalska K. , Wisniewska J. , Breborowicz A. , Gahl G.M. , Frei U. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000; 11(4): 729–39.

Witowski J. , Wisniewska J. , Korybalska K. , Bender T.O. , Breborowicz A. , Gahl G.M. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001; 12: 2434–41.

Tauer A. , Schmitt R. , Knerr T. , Schaub T.P. , Lage C. , Passlick–Deetjen J. Formation of the glucose degradation product 3-deoxyglucosone and other carbonyl-compounds in single- or double-chamber peritoneal dialysis fluids (Abstract). Perit Dial Int 2000; 20(1): 142.

Jörres A. , Witowski J. , Mauder B. , Gahl G.M. , Frei U. , Passlick–Deetjen J. Mesothelial biocompatibility of Balance, a novel two-chambered, lactate-buffered peritoneal dialysis solution (Abstract). In: Nephrology 1999. Proceedings of the XVth International Congress of Nephrology; 2–6 May 1999; Buenos Aires, Argentina. 1999: 441.

Witowski J. , Bender T.O. , Gahl G.M. , Frei U. , Passlick– Deetjen J. , Jörres A. Balance—a new two-compartment bag PDF—displays reduced glucose degradation product (GDP)–related toxicity towards human peritoneal mesothelial cells (HPMC) (Abstract). J Am Soc Nephrol 2000; 11: 222.

Park M.S. , Lee H.A. , Chu W.S. , Yang D.H. , Hwang A.D. Peritoneal accumulation of AGE and peritoneal membrane permeability. Perit Dial Int 2000; 20(4): 452–60.

Niwa H. , Takeda A. , Wakai M. , Miyata T. , Yasuda Y. , Mitsuma T. Accelerated formation of Nε-(carboxy-methyl)lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons. Biochem Biophys Res Commun 1998; 248: 93–7.

Wells Knecht K.J. , Brinkmann E. , Wells Knecht M.C. , Litchfield J.E. , Ahmed M.U. , Reddy S. New bio-markers of Maillard reaction damage to proteins. Nephrol Dial Transplant 1996; 11(Suppl 5): 41–7.

Lamb E.J. , Cattell W.R. , Dawnay A.B. In vitro formation of advanced glycation end products in peritoneal dialysis fluid. Kidney Int 1995; 47: 1768–74.

Schalkwijk C.G. , Posthuma N. , ten Brink H.J. , ter Wee P.M. , Teerlink T. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999; 19(4): 325–33.

Niwa T. , Takeda N. , Miyazaki T. , Yoshizumi H. , Tatematsu A. , Maeda K. Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction in uremic patients. Nephron 1995; 69: 438–43.

Odani H. , Shinzato T. , Usami J. , Matsumoto Y. , Brinkmann Frye E. , Baynes J.W. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia. FEBS Lett 1998; 427: 381–5.

Miyata T. , Horie K. , Ueda Y. , Fujita Y. , Izuhara Y. , Hirano H. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 2000; 58(1): 425–35.

Millar D. , Holmes C. , Faict D. , Dawnay A. Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation. Adv Perit Dial 1998; 14: 191–4.

Chio K. , Tappel A. Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry 1969; 8: 2821–6.

Pischetsrieder M. Chemistry of glucose and biochemical pathways of biological interest. Perit Dial Int 2000; 20(Suppl 2): S26–30.

Tauer A. , Knerr T. , Niwa T. , Schaub T.P. , Lage C. , Passlick– Deetjen J. In vitro formation of Nε-(carboxy-methyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis. Biochem Biophys Res Commun 2001; 280(5): 1408–14.